Copertina

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Zheng Ma, Ge Cui, Lijie Dou, Fangfang Chen, Hexin Xie
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Preparation of Dearomatized p‐Coumaric Acid Derivatives as DNA Damage Response Inhibitors with Potent In Vitro Antitumor Effect
di: Laura Fási, et al.
Pubblicazione: (2024)

In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
di: Frankie S. Mak, et al.
Pubblicazione: (2026)

Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors
di: Yaojia Li, et al.
Pubblicazione: (2025)

Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
di: Kelly A. McCarthy, et al.
Pubblicazione: (2024)

Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy
di: Gaurav Sheth, et al.
Pubblicazione: (2025)

An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
di: Yazhou Wang, et al.
Pubblicazione: (2026)

Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors
di: Cornelia Zumbrunn, et al.
Pubblicazione: (2025)

Design and Synthesis of Pyrimidino[4,5‐ d ]Pyrimidine‐Based Compounds as Potent B‐RAF V600E Inhibitors
di: Eleftheria A. Georgiou, et al.
Pubblicazione: (2026)

Synthesis of 2‐Aryl(alkyl)benzimidazole Hydroxamic Acids as HDAC Inhibitors with Anti‐Angiogenesis Properties
di: Yi‐Ting Liu, et al.
Pubblicazione: (2026)

Design and Synthesis of Potent Ridaifen Analogues: Evaluation as Anticancer, 20S Proteasomal Inhibitors, and Antiebola Virus Agents through In vitro and In Silico Studies
di: Merna A. Vector, et al.
Pubblicazione: (2025)

Front Cover: Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors (ChemMedChem 21/2025)
di: Yaojia Li, et al.
Pubblicazione: (2025)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
di: Jochem Nelen, et al.
Pubblicazione: (2026)

Cover Feature: An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors (ChemMedChem 6/2026)
di: Yazhou Wang, et al.
Pubblicazione: (2026)

Artificial Ion Transporters as Potent Therapeutics for Channelopathies
di: Wei Huang, et al.
Pubblicazione: (2024)

Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents
di: Victória C. Tietz, et al.
Pubblicazione: (2024)

Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
di: Marcos Couto, et al.
Pubblicazione: (2026)

Corrigendum: Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
di: Marcos Couto, et al.
Pubblicazione: (2026)

Diversity Oriented Synthesis of Novel Xanthones Reveal Potent Doxorubicin‐Inspired Analogs
di: Jonas W. Meringdal, et al.
Pubblicazione: (2024)

Substituted Benzylidene‐3‐Oxo‐3,4‐Dihydro‐2 H ‐Benzo[ b ][1,4]thiazine‐6‐Carboxylic Acid Analogs as Dynamin GTPase Inhibitors
di: Andrew J. S. Lin, et al.
Pubblicazione: (2025)

Virtual and in Vitro Screening Employing a Repurposing Approach Reveal 13‐cis‐Retinoic Acid is a PTP1B Inhibitor
di: Reyna Del Carmen Navarrete‐Mondragón, et al.
Pubblicazione: (2024)

Cuproptosis and Cuproptosis‐Based Synergistic Therapy for Cancer Treatment
di: Zhiyang Shen, et al.
Pubblicazione: (2024)

Tryptophan‐Rich Short Peptide Amphiphile‐Mediated Synthesis of Silver Nanoparticles for Potent Antibacterial Applications
di: Govind Singh, et al.
Pubblicazione: (2025)

Bushy‐Tailed Multicationic Quaternary Phosphonium Compounds: Potent Amphiphilic Disinfectants with Promising Therapeutic Indices
di: Diana Rachii, et al.
Pubblicazione: (2024)

Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity
di: Sachin B. Wagh, et al.
Pubblicazione: (2024)

Binding‐Site Switch for Protein Kinase CK2 Inhibitors
di: Dylan Grenier, et al.
Pubblicazione: (2025)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
di: Mehmet Ali Yucel, et al.
Pubblicazione: (2024)

CORRIGENDUM: Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2‐Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres
Pubblicazione: (2024)

Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy
di: Sarfraz Ahmad, et al.
Pubblicazione: (2025)

Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation Potential
di: Abdelsattar M. Omar, et al.
Pubblicazione: (2025)

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
di: Trent D. Ashton, et al.
Pubblicazione: (2024)

Benzamide Derivatives of Thioacridine as DYRK2 and DYRK3 Dual Inhibitors
di: Jean Roussel, et al.
Pubblicazione: (2025)

Polymethoxylated N ‐Carboranyl Isoquinolinones: A New Scaffold for ABCG2 Inhibitors
di: Lydia Kuhnert, et al.
Pubblicazione: (2026)

Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi
di: Siyao Chen, et al.
Pubblicazione: (2026)

Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain‐Containing Inositol 5’‐Phosphatase (SHIP)
di: Angela M. Pacherille, et al.
Pubblicazione: (2025)

Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
di: Artem Chayka, et al.
Pubblicazione: (2024)

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor
di: Mario Saletti, et al.
Pubblicazione: (2025)

Next‐Generation Bcl‐2 Inhibitors: Design and Evaluation of Indolyl‐Triazole Derivatives with Anticancer Potential
di: Ahmed M. Almehdi, et al.
Pubblicazione: (2025)

Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
di: Lukas Gardner, et al.
Pubblicazione: (2024)

Design, Synthesis, and Evaluation of New Polyhydroxylated B is ‐Chalcones as Potential COX‐2 Selective Inhibitors
di: Rui Pereira, et al.
Pubblicazione: (2026)

Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy
di: Xiaowen Feng, et al.
Pubblicazione: (2024)